[1] Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome[J]. Lancet, 2006, 367:1605-1617.
[2] Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH. Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients < 65 years old in the United States[J]. Pituitary, 2015, 18:283-289.
[3] Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines[J]. Clin Endocrinol (Oxf), 2004, 61:768-777.
[4] Wagner J, Langlois F, Lim DST, McCartney S, Fleseriu M. Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing's syndrome:a systematic meta-analysis[J]. Front Endocrinol (Lausanne), 2019, 9:805.
[5] Stuijver DJ, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, van den Berg G, Pereira AM, de Herder WW, Wagenmakers MA, Kerstens MN, Zelissen PM, Fliers E, Schaper N, Drent ML, Dekkers OM, Gerdes VE. Incidence of venous thromboembolism in patients with Cushing's syndrome:a multicenter cohort study[J]. J Clin Endocrinol Metab, 2011, 96:3525-3532.
[6] Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of Cushing's syndrome:a consensus statement[J]. J Clin Endocrinol Metab, 2003, 88:5593-5602.
[7] Suarez MG, Stack M, Hinojosa-Amaya JM, Mitchell MD, Varlamov EV, Yedinak CG, Cetas JS, Sheppard B, Fleseriu M. Hypercoagulability in Cushing syndrome, prevalence of thrombotic events:a large, single-center, retrospective study[J]. J Endocr Soc, 2019, 4:bvz033.
[8] China pituitary adenoma specialist council. Consensus of Chinese experts on diagnosis and treatment of Cushing's disease[J]. Zhonghua Yi Xue Za Zhi, 2016, 96:835-840.[ 中国垂体腺瘤协作组. 中国库欣病诊治专家共识[J]. 中华医学杂志, 2016, 96:835-840.]
[9] Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Áinle FN, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS):the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)[J]. Eur Respir J, 2019, 54:1901647.
[10] Liu ZH, Lu L, Chen S, Pan H, Zhu HJ, Gong FY, Yang HB, Wang LJ, Deng K. Blood coagulation function change and influence factors in Cushing's syndrome and obesity[J]. Zhonghua Yi Xue Za Zhi, 2016, 96:850-853.[ 刘之慧, 卢琳, 陈适, 潘慧, 朱惠娟, 龚凤英, 阳洪波, 王林杰, 邓侃. 库欣综合征和肥胖症患者凝血功能的改变及影响因素[J]. 中华医学杂志, 2016, 96:850-853.]
[11] Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM. Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome[J]. J Endocrinol Invest, 2000, 23:145-150.
[12] van der Pas R, Leebeek FW, Hofland LJ, de Herder WW, Feelders RA. Hypercoagulability in Cushing's syndrome:prevalence, pathogenesis and treatment[J]. Clin Endocrinol (Oxf), 2013, 78:481-488.
[13] Sun BW, Feng M, Zhang JL, Kang J. Advances in clinical diagnosis of Cushing's disease[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2020, 20:162-165.[ 孙博文, 冯铭, 张家亮, 康军. 库欣病临床诊断研究进展[J]. 中国现代神经疾病杂志, 2020, 20:162-165.]
[14] Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Treatment of Cushing's syndrome:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2015, 100:2807-2831.
[15] Jiménez D, Escobar C, Martí D, Díaz G, César J, García-Avello A, Sueiro A, Yusen RD. Association of anaemia and mortality in patients with acute pulmonary embolism[J]. Thromb Haemost, 2009, 102:153-158.
[16] Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C, Swerdloff RS, Kelly DF. Clinical review:early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease[J]. J Clin Endocrinol Metab, 2006, 91:7-13.
[17] Kearon C, de Wit K, Parpia S, Schulman S, Afilalo M, Hirsch A, Spencer FA, Sharma S, D'Aragon F, Deshaies JF, Le Gal G, Lazo-Langner A, Wu C, Rudd-Scott L, Bates SM, Julian JA; PEGeD Study Investigators. Diagnosis of pulmonary embolism with d-Dimer adjusted to clinical probability[J]. N Engl J Med, 2019, 381:2125-2134.
[18] Olié V, Zhu T, Martinez I, Scarabin PY, Emmerich J. Sex-specific risk factors for recurrent venous thromboembolism[J]. Thromb Res, 2012, 130:16-20.
[19] Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence:the longitudinal investigation of thromboembolism etiology[J]. Arch Intern Med, 2002, 162:1182-1189. |